Literature DB >> 27010614

Hereditary and inflammatory neuropathies: a review of reported associations, mimics and misdiagnoses.

Yusuf A Rajabally1, David Adams2, Philippe Latour3, Shahram Attarian4.   

Abstract

Distinguishing between hereditary and inflammatory neuropathy is usually straightforward on clinical grounds with the help of a family history. There are nevertheless cases where the distinction is less clear. The advent of molecular genetics has in the past several years aided confirmatory diagnosis for an increasing proportion of patients with genetic neuropathy. Various reports have described associations of Charcot-Marie-Tooth disease with a suspected or confirmed inflammatory neuropathy occasionally responding to immunotherapy. Possible predisposition to an inflammatory component was suggested in a subset of patients. Such reports have, however, been relatively few in number, suggesting the rarity of such associations and of such a predisposition if it exists. There have been a number of publications detailing clinical presentations suggestive of inflammatory neuropathy in patients with a known or later proven genetic aetiology, and subsequently felt to be part of the phenotype rather than representing an association. A number of genetically mediated multisystemic diseases with neuropathy have otherwise been reported as mimicking chronic inflammatory demyelinating polyneuropathy (CIDP). The most common example is that of familial amyloid polyneuropathy, of particular concern for the clinician when misdiagnosed as CIDP, in view of the therapeutic implications. We review the literature on reported associations, mimics and misdiagnoses of hereditary and inflammatory neuropathy and attempt to determine a practical approach to the problem in clinical practice using clinical features, electrophysiology, histopathology and targeted early genetic testing. The issue of attempting immunomodulatory therapy is discussed in view of the published literature. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Keywords:  GENETICS; NEUROPATHY; NEUROPHYSIOL, CLINICAL; PERIPHERAL NEUROPATHOLOGY

Mesh:

Year:  2016        PMID: 27010614     DOI: 10.1136/jnnp-2015-310835

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  14 in total

Review 1.  Hereditary neuropathy with liability to pressure palsies.

Authors:  Shahram Attarian; Farzad Fatehi; Yusuf A Rajabally; Davide Pareyson
Journal:  J Neurol       Date:  2019-04-15       Impact factor: 4.849

2.  Sphingosine 1-phosphate lyase deficiency causes Charcot-Marie-Tooth neuropathy.

Authors:  Derek Atkinson; Jelena Nikodinovic Glumac; Bob Asselbergh; Biljana Ermanoska; David Blocquel; Regula Steiner; Alejandro Estrada-Cuzcano; Kristien Peeters; Tinne Ooms; Els De Vriendt; Xiang-Lei Yang; Thorsten Hornemann; Vedrana Milic Rasic; Albena Jordanova
Journal:  Neurology       Date:  2017-01-11       Impact factor: 9.910

3.  Genetic and clinical characteristics of hereditary transthyretin amyloidosis in endemic and non-endemic areas: experience from a single-referral center in Japan.

Authors:  Taro Yamashita; Mitsuharu Ueda; Yohei Misumi; Teruaki Masuda; Toshiya Nomura; Masayoshi Tasaki; Kotaro Takamatsu; Keiko Sasada; Konen Obayashi; Hirotaka Matsui; Yukio Ando
Journal:  J Neurol       Date:  2017-11-24       Impact factor: 4.849

4.  CIDP, CMT1B, or CMT1B plus CIDP?

Authors:  Davide Cardellini; Giampietro Zanette; Federica Taioli; Laura Bertolasi; Sergio Ferrari; Tiziana Cavallaro; Gian Maria Fabrizi
Journal:  Neurol Sci       Date:  2020-10-18       Impact factor: 3.307

5.  Reversible inflammatory neuropathy superimposed on Charcot-Marie-Tooth type 1A disease.

Authors:  José Gazulla; Carmen Almárcegui; José Berciano
Journal:  Neurol Sci       Date:  2017-11-21       Impact factor: 3.307

6.  PMP22 Gene-Associated Neuropathies: Phenotypic Spectrum in a Cohort from India.

Authors:  Madhu Nagappa; Shivani Sharma; Periyasamy Govindaraj; Yasha T Chickabasaviah; Ramesh Siram; Akhilesh Shroti; Monojit Debnath; Sanjib Sinha; Parayil S Bindu; Arun B Taly
Journal:  J Mol Neurosci       Date:  2020-01-28       Impact factor: 3.444

7.  Transthyretin familial amyloid polyneuropathy (TTR-FAP): Parameters for early diagnosis.

Authors:  Fabiola Escolano-Lozano; Ana Paula Barreiros; Frank Birklein; Christian Geber
Journal:  Brain Behav       Date:  2017-12-19       Impact factor: 2.708

8.  Melatonin Treatment Reduces Oxidative Damage and Normalizes Plasma Pro-Inflammatory Cytokines in Patients Suffering from Charcot-Marie-Tooth Neuropathy: A Pilot Study in Three Children.

Authors:  Mariam Chahbouni; María Del Señor López; Antonio Molina-Carballo; Tomás de Haro; Antonio Muñoz-Hoyos; Marisol Fernández-Ortiz; Ana Guerra-Librero; Darío Acuña-Castroviejo
Journal:  Molecules       Date:  2017-10-14       Impact factor: 4.411

9.  Hidden Charcot-Marie-Tooth 1A as Revealed by Peripheral Nerve Imaging.

Authors:  Kazumoto Shibuya; Toshiki Yoshida; Sonoko Misawa; Yukari Sekiguchi; Minako Beppu; Hiroshi Amino; Yo-Ichi Suzuki; Tomoki Suichi; Atsuko Tsuneyama; Keigo Nakamura; Satoshi Kuwabara
Journal:  Intern Med       Date:  2019-07-10       Impact factor: 1.271

10.  Whole exome sequencing establishes diagnosis of Charcot-Marie-Tooth 4J, 1C, and X1 subtypes.

Authors:  Kleita Michaelidou; Ioannis Tsiverdis; Sophia Erimaki; Dimitra Papadimitriou; Georgios Amoiridis; Alexandros Papadimitriou; Panayiotis Mitsias; Ioannis Zaganas
Journal:  Mol Genet Genomic Med       Date:  2020-02-05       Impact factor: 2.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.